Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
See Latest ArticlesThe efficacy of oral ondansetron and dexamethasone for the prevention of acute chemotherapy-induced nausea and vomiting associated with moderately emetogenic chemotherapy – a retrospective audit
European Journal of Cancer Care, 09/10/09
Ng W et al. – The optimal dose of oral ondansetron for the prevention of acute chemotherapy–induced nausea and vomiting (CINV) resulting from moderately emetogenic chemotherapy (MEC) is unknown. In this study, the use of 8 mg oral ondansetron plus 8 mg oral dexamethasone achieved control of acute emesis in 75% of all patients receiving MEC which is comparable to previously reported rates of 70–80%. The benefits of using oral pre–chemotherapy anti–emetics include reduction in the costs of drugs and nursing administration time.
Related Articles
Phase 2 trial results with the novel neurokinin-1 receptor antagonist casopitant in combination with ondansetron and dexamethasone for the prevention of chemotherapy-induced nausea and vomiting in cancer patients receiving moderately emetogenic chemotherapy
Cancer, 10/20/09
Relevance Score: 89%
Ondansetron added to lidocaine for intravenous regional anaesthesia
European Journal of Anaesthesiology, 11/12/09
Relevance Score: 87%
Casopitant improves the quality of life in patients receiving highly emetogenic chemotherapy
Supportive Care in Cancer, 11/10/09
Relevance Score: 87%
Ropivacaine Spinal Anesthesia Is Not Antagonized by Ondansetron Pretreatment
Anesthesia & Analgesia, 10/26/09
Relevance Score: 87%
Combination therapy in the prevention of ponv after strabismus surgery in children: granisetron, ondansetron, midazolam with dexamethasone
Middle East Journal of Anesthesiology, 10/08/09
Relevance Score: 84%
Today in Pharmacology/Therapy...keeping you current
Receive free subspecialty "5-minute updates" via email
Management of patients with advanced bladder cancer following major response to systemic chemotherapy
Expert Review of Anticancer Therapy, 12/04/09
ML17032 trial: capecitabine/cisplatin versus 5-fluorouracil/cisplatin as first-line therapy in advanced gastric cancer
Expert Review of Anticancer Therapy, 12/04/09
Degarelix 240/80 mg: a new treatment option for patients with advanced prostate cancer
Expert Review of Anticancer Therapy, 12/04/09
Today in Side Effects...keeping you current
Receive free subspecialty "5-minute updates" via email
Immunoglobulin G Fc Receptor FcgammaRIIIa 158 V/F Polymorphism Correlates With Rituximab-Induced Neutropenia After Autologous Transplantation in Patients With Non-Hodgkin's Lymphoma
Journal of Clinical Oncology, 12/04/09
Cytidine Deaminase Residual Activity in Serum Is a Predictive Marker of Early Severe Toxicities in Adults After Gemcitabine-Based Chemotherapies
Journal of Clinical Oncology, 12/04/09
Hepatic Toxicities Associated with the Use of Preoperative Systemic Therapy in Patients with Metastatic Colorectal Adenocarcinoma to the Liver
The Oncologist, 12/03/09
Sponsor
Article Search
Sponsor
Sponsor